Kesar India Allots 71,428 Shares from Warrants
71,428 equity shares allotted; ₹350 issue price per share.
Reader Takeaway: Procedural share allotment finalizes warrants; increases paid-up capital.
What just happened
Kesar India Limited's Preferential Issue Committee has approved the allotment of 71,428 equity shares to Kanhaiya Lal Gupta, a non-promoter investor. This allotment follows the conversion of fully convertible warrants that were originally issued on September 18, 2025. The shares were issued at a price of ₹350 per share on a private placement basis.
Why this matters
This corporate action updates the company's share capital structure. The allotment leads to an increase in the total paid-up equity share capital and the total number of outstanding shares. For existing shareholders, it signifies the finalization of a financial commitment related to the earlier warrant issue.
The backstory
The warrants were initially allotted on September 18, 2025. The current allotment is a consequence of the holder exercising their right to convert these warrants into equity shares as per the agreed terms and pricing.
What changes now
Following the allotment, Kesar India's paid-up equity share capital stands at ₹30.17 crore, with a total of 3,01,71,320 equity shares of ₹10 face value each.
Risks to watch
While this is a procedural event, significant dilution can occur if a large number of warrants are converted. Investors should monitor the overall increase in outstanding shares.
Peer comparison
Kesar India operates in the diversified manufacturing sector. Shareholder dilution from warrant conversion is a common occurrence across listed entities, especially during periods of capital raising or restructuring.
Context metrics (time-bound)
- Allotted Shares: 71,428 equity shares
- Issue Price: ₹350 per share
- Conversion Date: From warrants allotted on September 18, 2025
- Post-Allotment Shares: 3,01,71,320
- Paid-up Equity Share Capital: ₹30.17 crore
What to track next
Investors should keep an eye on future company disclosures regarding its capital structure and any further corporate actions. Monitoring the company's financial performance post-allotment will also be crucial.
